HeyJaredIn the Pipeline
This is a podcast about advancements in clinical trials as they emerge, before regulatory milestones or publication of associated data. The views expressed are my own, and I have no financial affiliations with the companies discussed, nor is this affiliated with any employer.
- Indexed episodes, last 90 days
- 1
- Latest publication
- Aug 25, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 25, 2026
Latest episodes
INTicing Intismeran Updates (8/10/26 - 8/24/26) (opens the original)
Read excerpt
Thank you all for your continued listenership after my hiatus! Microphone quality to be fixed for the next episode. If you have any questions, please reach out at inthepipelinepodcast@gmail.com or on Twitter/X @tdonatellov. Sources: Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma Update on eVOLVE-Lung02
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.